APA (7th ed.) Citation

Frey, M., Smigielski, L., Tini, E., Fekete, S., Fleischhaker, C., Wewetzer, C., . . . Egberts, K. M. (2023). Therapeutic drug monitoring in children and adolescents: Findings on fluoxetine from the TDM-VIGIL trial. Pharmaceutics, 15(9), . https://doi.org/10.3390/pharmaceutics15092202

Chicago Style (17th ed.) Citation

Frey, Michael, et al. "Therapeutic Drug Monitoring in Children and Adolescents: Findings on Fluoxetine from the TDM-VIGIL Trial." Pharmaceutics 15, no. 9 (2023). https://doi.org/10.3390/pharmaceutics15092202.

MLA (9th ed.) Citation

Frey, Michael, et al. "Therapeutic Drug Monitoring in Children and Adolescents: Findings on Fluoxetine from the TDM-VIGIL Trial." Pharmaceutics, vol. 15, no. 9, 2023, https://doi.org/10.3390/pharmaceutics15092202.